/C O R R E C T I O N -- The Galien Foundation/

In the news release, The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup", issued 13-Aug-2026 by The Galien Foundation over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"

Celebrating 20 Years of Honoring the Digital Breakthroughs, Pioneering Startups, and Ecosystems Driving the Future of Healthcare

NEW YORK, Aug. 13, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, announced today the 2026 Prix Galien USA Award nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup." Winners will be honored during the Prix Galien USA Awards Ceremony on October 29, 2026, at the American Museum of Natural History in New York City.

"Witnessing the incredible momentum in medical technology, digital health, and startup ventures is inspiring," said Kenneth C. Frazier, Co-Chair of the Galien Forum, Prix Galien USA Awards Committee. "As we celebrate two decades of the Prix Galien USA Awards, we look forward to honoring this new class of nominees whose inventive work epitomizes the future of health and our collective commitment to improving lives through scientific brilliance."

Marking two decades of shaping medicine for patients worldwide, The Galien Foundation continues to inspire spirited collaboration between science and industry leaders on the most critical topics in medical technology, entrepreneurship, and equity.

"We applaud this year's remarkable Prix Galien USA nominees as we mark twenty years of excellence in medical technology, digital health, and entrepreneurship," said Bruno Cohen, Chairman of The Galien Foundation. "Their achievements beautifully demonstrate how scientific advancements can transform human lives and improve the wellbeing of our planet."

To qualify, each candidate must demonstrate tremendous potential to improve human health and for "Best Medical Technology" must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.

The following candidates have been selected as the 2026 Prix Galien USA nominees:

Best Digital Health Solution (Nominees)

Best Medical Technology (Nominees)

Incubators, Accelerators and Equity (Nominees)

Best Startup (Nominees)

Prix Galien Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup Committee 2026

Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck

Roch DOLIVEUX
Honorary CEO, UCB

Dr. Mikael DOLSTEN
Former Chief Scientific Officer & President, Pfizer Research and Development

Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson

Penny HEATON
M.D., Global Head, Office of the Chief Medical Officer, Johnson & Johnson

Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon

Joel S. MARCUS
Executive Chairman & Founder, Alexandria

Christophe WEBER,
Healthcare Executive, Former CEO Takeda Pharmaceutical

Elias ZERHOUNI
Former Head of Global R&D, Sanofi

About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve human health. Its vision is to serve as a catalyst for the development of the next generation of treatments and technologies that will transform medical practice and save lives. Established in Paris in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien is widely regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

Today, the Prix Galien operates through 16 chapters spanning more than 75 countries across Africa, the Americas, Asia, and Europe. Expansion is currently underway in China, Singapore, and Australia.

In 2025, the Foundation launched the inaugural Prix Galien Bridges Forum and Awards Ceremony at the Nobel Forum in Stockholm, spanning Northern and Southern Europe, Israel, and the Middle East, and the first-ever Patient Summit for Prix Galien USA, reinforcing its commitment to science without borders.

The Nobel Prize and the Prix Galien share a common birthplace in Paris, where Alfred Nobel signed his last will and testament in 1895. However, while the Nobel Prize in Physiology or Medicine recognizes up to three individuals for specific discoveries, the Prix Galien honors the collaborative spirit and multidisciplinary progress that define modern biopharmaceutical innovation.

For more information, visit www.galienfoundation.org.

Follow the Foundation on social media: 
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn 
https://www.linkedin.com/company/the-galien-foundation/ 

Media Contact: 
Kara Bradley
Finn Partners 
[email protected]
646-213-7243

Correction:  Future Doctor Inc has been added to the list of Best Digital Health Solution nominees.

SOURCE The Galien Foundation